Egyptian Journal of Chest Disease and Tuberculosis (Jan 2021)
Dilemma of antiviral treatment in coronavirus 2019
Abstract
There are four classes of Coronaviruses designated as alpha, beta, gamma and delta. CoV-2 attacks the lower respiratory system to cause severe pneumonia, but it may also affect other organs leading to multiple organ failure. The choice for antiviral treatment for CoV-2 depends on the timing and the severity of the case. Although there is no antiviral designed specifically for treating corona virus, several agents are tried such as hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, and Favipiravir. The mechanism of each drug is diacussed in detail below. In addition, ivermectin has started to emerge as a new candidate therapeutic against SARS-CoV-2/ COVID-19.
Keywords